Barbell Medicine Podcast

Q&A: Cholesterol Lowering, Volume vs. Intensity For Hypertrophy Volume, Zone 2 Efficiency, and More

Nov 14, 2025
In this Q&A, Dr. Jordan Feigenbaum dives into cholesterol management, comparing statins with PCSK9 inhibitors. He emphasizes that high training volume trumps intensity for hypertrophy gains. Listeners learn how to regulate training load effectively using RPE-based strategies. Dr. Feigenbaum critiques Pilates as inadequate for strength goals and discusses the real benefits of Zone 2 cardio, noting its role in conditioning but not as a superior method. Get ready for insightful health and training tips!
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ADVICE

Prefer Statins Before PCSK9 For Most

  • Start with a statin for most people before using expensive PCSK9 inhibitors unless high risk justifies it.
  • Discuss need and risk with your physician rather than defaulting to monoclonal antibodies.
INSIGHT

Cholesterol Risk Is Cumulative

  • Lifetime exposure to atherogenic lipoproteins (LDL, TG, ApoB) determines heart disease risk.
  • Lowering LDL as much as possible across life reduces risk, with genetic low-LDL showing the least disease.
INSIGHT

Volume Outweighs Intensity For Growth

  • Hypertrophy requires hitting a functional intensity threshold, not a single ideal load.
  • Once threshold is met, volume drives growth; more sets usually mean more hypertrophy if tolerated.
Get the Snipd Podcast app to discover more snips from this episode
Get the app